Revvity, Inc.
Revvity, Inc. (RVTY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RVTY · as of Jun 8, 2026
Key Statistics
Explore Revvity, Inc. Data
rvty stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 29 · Buy rate: 51.7%
The RVTY analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $108.88, representing +10.68% upside from the current price of $98.37.
Competitors & Peers
rvty competitorsRVTY
ALGN
CRL
ENSG
EXAS
GHStock Performance
Full HistoryAbout Revvity, Inc.
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions a…
what is revvity, inc. · rvty stock overview · revvity, inc. company profile · who is revvity, inc. ceo · rvty NYSE · revvity, inc. headquarters · revvity, inc. business segments
About Stock Overview & Key Data
Revvity, Inc. (RVTY) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Jul 6, 1965. As of the latest trading session, RVTY stock price is $98.37, with a market capitalization of $11.0B. The stock has returned +5.91% over the past 12 months and +1.67% year-to-date.
According to 29 Wall Street analysts, the consensus rating for Revvity, Inc. stock is Buy, with an average 12-month price target of $108.88. In fiscal year 2025, Revvity, Inc. reported revenue of $2.9B and net income of $241.7M. For detailed data — including Revvity, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Revvity, Inc. (RVTY) stock price is $98.37. The stock is traded on NYSE under the ticker symbol RVTY. The 52-week range is $81.22 – $118.30.